+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gonorrhea Therapeutics Market 2025-2029- Product Image
Gonorrhea Therapeutics Market 2025-2029- Product Image
New

Gonorrhea Therapeutics Market 2025-2029

  • PDF Icon

    Report

  • 220 Pages
  • July 2025
  • Region: Global
  • TechNavio
  • ID: 5135918
1h Free Analyst Time
REQUEST FREE SAMPLE
Description Jump to:

Rising Government Initiatives to Combat Antibiotic Resistance is a Key Trend Gaining Market Momentum

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The gonorrhea therapeutics market is forecasted to grow by USD 583 million during 2024-2029, accelerating at a CAGR of 5.7% during the forecast period. The report on the gonorrhea therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of gonorrhea, high-risk complications associated with gonorrhea, and growing use of new diagnostic tests.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The gonorrhea therapeutics market is segmented as below:

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Therapy

  • Monotherapy
  • Combination therapy

By Route Of Administration

  • Intramuscular
  • Oral
  • Intravenous
  • Injectable

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising government initiatives to combat antibiotic resistance as one of the prime reasons driving the gonorrhea therapeutics market growth during the next few years. Also, advent of vaccines for prevention of gonorrhea and increased adoption of expedited partner therapy will lead to sizable demand in the market.

The report on the gonorrhea therapeutics market covers the following areas:

  • Gonorrhea Therapeutics Market sizing
  • Gonorrhea Therapeutics Market forecast
  • Gonorrhea Therapeutics Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gonorrhea therapeutics market vendors that include Apotex Inc., Aurobindo Pharma Ltd., Bristol Myers Squibb Co., Cipla Inc., Debiopharm International SA, Entasis Therapeutics, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Lupin Ltd., Mayne Pharma Group Ltd., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Therapyx Inc. Also, the gonorrhea therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Therapy
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Gonorrhea Therapeutics Market 2019 - 2023
Historic Market Size - Data Table on Global Gonorrhea Therapeutics Market 2019 - 2023 ($ million)
5.2 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.3 Therapy segment analysis 2019 - 2023
Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
5.4 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The impact of AI in the global gonorrhea therapeutics market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Distribution Channel
8.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
8.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
8.3 Hospital pharmacies - Market size and forecast 2024-2029
Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
8.4 Retail pharmacies - Market size and forecast 2024-2029
Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
8.5 Online pharmacies - Market size and forecast 2024-2029
Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Therapy
9.1 Market segments
Chart on Therapy - Market share 2024-2029 (%)
Data Table on Therapy - Market share 2024-2029 (%)
9.2 Comparison by Therapy
Chart on Comparison by Therapy
Data Table on Comparison by Therapy
9.3 Monotherapy - Market size and forecast 2024-2029
Chart on Monotherapy - Market size and forecast 2024-2029 ($ million)
Data Table on Monotherapy - Market size and forecast 2024-2029 ($ million)
Chart on Monotherapy - Year-over-year growth 2024-2029 (%)
Data Table on Monotherapy - Year-over-year growth 2024-2029 (%)
9.4 Combination therapy - Market size and forecast 2024-2029
Chart on Combination therapy - Market size and forecast 2024-2029 ($ million)
Data Table on Combination therapy - Market size and forecast 2024-2029 ($ million)
Chart on Combination therapy - Year-over-year growth 2024-2029 (%)
Data Table on Combination therapy - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Therapy
Market opportunity by Therapy ($ million)
Data Table on Market opportunity by Therapy ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
10.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
10.3 Intramuscular - Market size and forecast 2024-2029
Chart on Intramuscular - Market size and forecast 2024-2029 ($ million)
Data Table on Intramuscular - Market size and forecast 2024-2029 ($ million)
Chart on Intramuscular - Year-over-year growth 2024-2029 (%)
Data Table on Intramuscular - Year-over-year growth 2024-2029 (%)
10.4 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
10.5 Intravenous - Market size and forecast 2024-2029
Chart on Intravenous - Market size and forecast 2024-2029 ($ million)
Data Table on Intravenous - Market size and forecast 2024-2029 ($ million)
Chart on Intravenous - Year-over-year growth 2024-2029 (%)
Data Table on Intravenous - Year-over-year growth 2024-2029 (%)
10.6 Injectable - Market size and forecast 2024-2029
Chart on Injectable - Market size and forecast 2024-2029 ($ million)
Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
Chart on Injectable - Year-over-year growth 2024-2029 (%)
Data Table on Injectable - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.10 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 Spain - Market size and forecast 2024-2029
Chart on Spain - Market size and forecast 2024-2029 ($ million)
Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Chart on Spain - Year-over-year growth 2024-2029 (%)
Data Table on Spain - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Apotex Inc.
Apotex Inc. - Overview
Apotex Inc. - Product / Service
Apotex Inc. - Key news
Apotex Inc. - Key offerings
SWOT
15.5 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
SWOT
15.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
15.7 Cipla Inc.
Cipla Inc. - Overview
Cipla Inc. - Business segments
Cipla Inc. - Key news
Cipla Inc. - Key offerings
Cipla Inc. - Segment focus
SWOT
15.8 Debiopharm International SA
Debiopharm International SA - Overview
Debiopharm International SA - Product / Service
Debiopharm International SA - Key news
Debiopharm International SA - Key offerings
SWOT
15.9 Entasis Therapeutics
Entasis Therapeutics - Overview
Entasis Therapeutics - Product / Service
Entasis Therapeutics - Key offerings
SWOT
15.10 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
15.11 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
SWOT
15.12 Hikma Pharmaceuticals Plc
Hikma Pharmaceuticals Plc - Overview
Hikma Pharmaceuticals Plc - Business segments
Hikma Pharmaceuticals Plc - Key news
Hikma Pharmaceuticals Plc - Key offerings
Hikma Pharmaceuticals Plc - Segment focus
SWOT
15.13 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Business segments
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
Lupin Ltd. - Segment focus
SWOT
15.14 Mayne Pharma Group Ltd.
Mayne Pharma Group Ltd. - Overview
Mayne Pharma Group Ltd. - Business segments
Mayne Pharma Group Ltd. - Key news
Mayne Pharma Group Ltd. - Key offerings
Mayne Pharma Group Ltd. - Segment focus
SWOT
15.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.16 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
SWOT
15.17 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
SWOT
15.18 Therapyx Inc.
Therapyx Inc. - Overview
Therapyx Inc. - Product / Service
Therapyx Inc. - Key offerings
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Gonorrhea Therapeutics Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits 39: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Distribution Channel
Exhibits 41: Data Table on Comparison by Distribution Channel
Exhibits 42: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 54: Market opportunity by Distribution Channel ($ million)
Exhibits 55: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 56: Chart on Therapy - Market share 2024-2029 (%)
Exhibits 57: Data Table on Therapy - Market share 2024-2029 (%)
Exhibits 58: Chart on Comparison by Therapy
Exhibits 59: Data Table on Comparison by Therapy
Exhibits 60: Chart on Monotherapy - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on Monotherapy - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on Monotherapy - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on Monotherapy - Year-over-year growth 2024-2029 (%)
Exhibits 64: Chart on Combination therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 65: Data Table on Combination therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 66: Chart on Combination therapy - Year-over-year growth 2024-2029 (%)
Exhibits 67: Data Table on Combination therapy - Year-over-year growth 2024-2029 (%)
Exhibits 68: Market opportunity by Therapy ($ million)
Exhibits 69: Data Table on Market opportunity by Therapy ($ million)
Exhibits 70: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits 71: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits 72: Chart on Comparison by Route of Administration
Exhibits 73: Data Table on Comparison by Route of Administration
Exhibits 74: Chart on Intramuscular - Market size and forecast 2024-2029 ($ million)
Exhibits 75: Data Table on Intramuscular - Market size and forecast 2024-2029 ($ million)
Exhibits 76: Chart on Intramuscular - Year-over-year growth 2024-2029 (%)
Exhibits 77: Data Table on Intramuscular - Year-over-year growth 2024-2029 (%)
Exhibits 78: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 82: Chart on Intravenous - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Intravenous - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Intravenous - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Intravenous - Year-over-year growth 2024-2029 (%)
Exhibits 86: Chart on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits 90: Market opportunity by Route of Administration ($ million)
Exhibits 91: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 93: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 94: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 95: Chart on Geographic comparison
Exhibits 96: Data Table on Geographic comparison
Exhibits 97: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 98: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibits 153: Market opportunity By Geographical Landscape ($ million)
Exhibits 154: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 155: Impact of drivers and challenges in 2024 and 2029
Exhibits 156: Overview on criticality of inputs and factors of differentiation
Exhibits 157: Overview on factors of disruption
Exhibits 158: Impact of key risks on business
Exhibits 159: Companies covered
Exhibits 160: Company ranking index
Exhibits 161: Matrix on companies position and classification
Exhibits 162: Apotex Inc. - Overview
Exhibits 163: Apotex Inc. - Product / Service
Exhibits 164: Apotex Inc. - Key news
Exhibits 165: Apotex Inc. - Key offerings
Exhibits 166: SWOT
Exhibits 167: Aurobindo Pharma Ltd. - Overview
Exhibits 168: Aurobindo Pharma Ltd. - Product / Service
Exhibits 169: Aurobindo Pharma Ltd. - Key offerings
Exhibits 170: SWOT
Exhibits 171: Bristol Myers Squibb Co. - Overview
Exhibits 172: Bristol Myers Squibb Co. - Product / Service
Exhibits 173: Bristol Myers Squibb Co. - Key news
Exhibits 174: Bristol Myers Squibb Co. - Key offerings
Exhibits 175: SWOT
Exhibits 176: Cipla Inc. - Overview
Exhibits 177: Cipla Inc. - Business segments
Exhibits 178: Cipla Inc. - Key news
Exhibits 179: Cipla Inc. - Key offerings
Exhibits 180: Cipla Inc. - Segment focus
Exhibits 181: SWOT
Exhibits 182: Debiopharm International SA - Overview
Exhibits 183: Debiopharm International SA - Product / Service
Exhibits 184: Debiopharm International SA - Key news
Exhibits 185: Debiopharm International SA - Key offerings
Exhibits 186: SWOT
Exhibits 187: Entasis Therapeutics - Overview
Exhibits 188: Entasis Therapeutics - Product / Service
Exhibits 189: Entasis Therapeutics - Key offerings
Exhibits 190: SWOT
Exhibits 191: F. Hoffmann La Roche Ltd. - Overview
Exhibits 192: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 193: F. Hoffmann La Roche Ltd. - Key news
Exhibits 194: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 195: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 196: SWOT
Exhibits 197: GlaxoSmithKline Plc - Overview
Exhibits 198: GlaxoSmithKline Plc - Business segments
Exhibits 199: GlaxoSmithKline Plc - Key news
Exhibits 200: GlaxoSmithKline Plc - Key offerings
Exhibits 201: GlaxoSmithKline Plc - Segment focus
Exhibits 202: SWOT
Exhibits 203: Hikma Pharmaceuticals Plc - Overview
Exhibits 204: Hikma Pharmaceuticals Plc - Business segments
Exhibits 205: Hikma Pharmaceuticals Plc - Key news
Exhibits 206: Hikma Pharmaceuticals Plc - Key offerings
Exhibits 207: Hikma Pharmaceuticals Plc - Segment focus
Exhibits 208: SWOT
Exhibits 209: Lupin Ltd. - Overview
Exhibits 210: Lupin Ltd. - Business segments
Exhibits 211: Lupin Ltd. - Key news
Exhibits 212: Lupin Ltd. - Key offerings
Exhibits 213: Lupin Ltd. - Segment focus
Exhibits 214: SWOT
Exhibits 215: Mayne Pharma Group Ltd. - Overview
Exhibits 216: Mayne Pharma Group Ltd. - Business segments
Exhibits 217: Mayne Pharma Group Ltd. - Key news
Exhibits 218: Mayne Pharma Group Ltd. - Key offerings
Exhibits 219: Mayne Pharma Group Ltd. - Segment focus
Exhibits 220: SWOT
Exhibits 221: Pfizer Inc. - Overview
Exhibits 222: Pfizer Inc. - Product / Service
Exhibits 223: Pfizer Inc. - Key news
Exhibits 224: Pfizer Inc. - Key offerings
Exhibits 225: SWOT
Exhibits 226: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 227: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 228: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 229: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 230: SWOT
Exhibits 231: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 232: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 233: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 234: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 235: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 236: SWOT
Exhibits 237: Therapyx Inc. - Overview
Exhibits 238: Therapyx Inc. - Product / Service
Exhibits 239: Therapyx Inc. - Key offerings
Exhibits 240: SWOT
Exhibits 241: Inclusions checklist
Exhibits 242: Exclusions checklist
Exhibits 243: Currency conversion rates for US$
Exhibits 244: Research methodology
Exhibits 245: Information sources
Exhibits 246: Data validation
Exhibits 247: Validation techniques employed for market sizing
Exhibits 248: Data synthesis
Exhibits 249: 360 degree market analysis
Exhibits 250: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global gonorrhea therapeutics market: Apotex Inc., Aurobindo Pharma Ltd., Bristol Myers Squibb Co., Cipla Inc., Debiopharm International SA, Entasis Therapeutics, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Lupin Ltd., Mayne Pharma Group Ltd., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Therapyx Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising government initiatives to combat antibiotic resistance."

According to the report, one of the major drivers for this market is the rising prevalence of gonorrhea.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Apotex Inc.
  • Aurobindo Pharma Ltd.
  • Bristol Myers Squibb Co.
  • Cipla Inc.
  • Debiopharm International SA
  • Entasis Therapeutics
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals Plc
  • Lupin Ltd.
  • Mayne Pharma Group Ltd.
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Therapyx Inc.

Related Topics

Related Reports

Endometriosis Drugs Market 2025-2029 - Product Image

Endometriosis Drugs Market 2025-2029

  • Report
  • 229 Pages
  • Global
From
Female Sexual Dysfunction Treatment Market 2025-2029 - Product Image

Female Sexual Dysfunction Treatment Market 2025-2029

  • Report
  • 204 Pages
  • Global
From
Gonorrhea Therapeutics Global Market Report 2025 - Product Image

Gonorrhea Therapeutics Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Gonorrhea Therapeutics - Global Strategic Business Report - Product Image

Gonorrhea Therapeutics - Global Strategic Business Report

  • Report
  • 140 Pages
  • Global
From
Invasive Aspergillosis Therapeutics Global Market Report 2025 - Product Image

Invasive Aspergillosis Therapeutics Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.